Abstract
Gene editing technologies, particularly CRISPR-Cas9, have revolutionized the potential for treating genetic disorders by enabling precise alterations to DNA. This article explores the latest advancements in gene editing techniques, their applications in treating genetic disorders, and the ethical implications surrounding their use. The article focuses on gene therapy strategies for monogenic diseases, advances in precision medicine, and challenges in translating gene editing from the laboratory to clinical practice. In addition, we discuss the promise of gene editing in addressing complex genetic conditions, such as cancer and neurological disorders.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Dr. James Smith (Author)